Human Islet Procurement
The Stanford IPR Core provides human islets to Stanford investigators for research. These islets are procured through arrangements with multiple high-quality sources, particularly the IsletCore at the University of Alberta (Edmonton), the UCSF Islet Core facility in the UCSF Diabetes Center, the Allegheny Health Network (Pittsburgh), and through in-house isolations.
Blanket MTA with University of Alberta Diabetes Institute (Edmonton) for human islet procurement (starting July 2017)
Our Islet Research Core (IRC) has negotiated a blanket MTA with the University of Alberta Diabetes Institute’s (ADI) Islet Core for human islet procurement for use by our Investigators. The blanket MTA enables researchers at Stanford to procure human islets for their research. This could also include non-islet pancreatic cells. In order to obtain islets through this MTA-enabled streamlined mechanism, each investigator should: 1) contact Seung Kim or Kent Jensen, 2) provide a PTA and copies of their approved protocols (APLAC and/or IRB human subjects exemption covering human islet use in, say, islet transplantation), 3) a copy of their Administrative Panel on Biosafety (APB) Protocol exemption (if necessary) and 4) a brief (1 page) description of their project.
For more information, contact the IPR Core Director.